Supporting projects developing innovative technologies for biomedical research, advancing current capabilities for acquiring biomedical knowledge.
Funding opportunity for academic-industrial partnerships to translate technologies for diagnosis and treatment in cancer research and care.
Grant supports partnerships between academia and industry to translate scientific discoveries into tools for disease research and care worldwide.
The National Cancer Institute funds early-stage proof-of-concept studies of innovative technologies for cancer characterization or biospecimen handling and quality control; clinical trials are not allowed.
This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.
NIH supports small, multidisciplinary teams using bioengineering to solve biomedical problems and advance tools, with optional trials to test functionality or performance, excluding phase III trials.